- Home
- OBIO vs CYBN Comparison
OBIO vs CYBN Comparison
Compare OBIO & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CYBN
- Stock Information
- Founded
- OBIO 2017
- CYBN 2019
- Country
- OBIO United States
- CYBN Canada
- Employees
- OBIO N/A
- CYBN N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CYBN Pharmaceuticals and Biotechnology
- Sector
- OBIO Health Care
- CYBN Health Care
- Exchange
- OBIO Nasdaq
- CYBN Nasdaq
- Market Cap
- OBIO 200.1M
- CYBN 229.8M
- IPO Year
- OBIO N/A
- CYBN N/A
- Fundamental
- Price
- OBIO $5.84
- CYBN $11.62
- Analyst Decision
- OBIO Strong Buy
- CYBN Strong Buy
- Analyst Count
- OBIO 4
- CYBN 3
- Target Price
- OBIO $15.75
- CYBN $45.50
- AVG Volume (30 Days)
- OBIO 57.1K
- CYBN 334.2K
- Earning Date
- OBIO 11-12-2024
- CYBN 11-13-2024
- Dividend Yield
- OBIO N/A
- CYBN N/A
- EPS Growth
- OBIO N/A
- CYBN N/A
- EPS
- OBIO N/A
- CYBN N/A
- Revenue
- OBIO $2,647,000.00
- CYBN N/A
- Revenue This Year
- OBIO $7.68
- CYBN N/A
- Revenue Next Year
- OBIO $110.40
- CYBN N/A
- P/E Ratio
- OBIO N/A
- CYBN N/A
- Revenue Growth
- OBIO N/A
- CYBN N/A
- 52 Week Low
- OBIO $4.22
- CYBN $6.50
- 52 Week High
- OBIO $11.69
- CYBN $21.66
- Technical
- Relative Strength Index (RSI)
- OBIO 51.19
- CYBN 58.44
- Support Level
- OBIO $5.56
- CYBN $10.26
- Resistance Level
- OBIO $6.50
- CYBN $12.80
- Average True Range (ATR)
- OBIO 0.53
- CYBN 1.00
- MACD
- OBIO 0.00
- CYBN 0.05
- Stochastic Oscillator
- OBIO 56.58
- CYBN 60.10
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.